Influence of Transplantable Melanomas on the Secretion of Cytokines by Hamster Peritoneal Macrophages

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 6, 1999, Pages 360-365

  Kozlowska, K ^a   Cichorek, M ^a   Zarzeczna, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; ONCOSTATIN M; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

AMELANOTIC MELANOMA; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; EXPERIMENTAL MELANOMA; HAMSTER; IMMUNOLOGY; MALE; PERITONEUM MACROPHAGE; SECRETION; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; CYTOKINES; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; MELANOMA, AMELANOTIC; MELANOMA, EXPERIMENTAL; MESOCRICETUS; NEOPLASM TRANSPLANTATION; ONCOSTATIN M; PEPTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033255789     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. AARDEN L. A., DE GROOT E. R., SCHAAP O. L. and LANSDORP P. M. (1987): Production of hybridoma growth factor by human monocytes. Eur. J. Immunol., 17, 1411-1416.
2. AHN M., SIZIOPIKOU P., PLATE M. D., CASEY L. and SILVER M. (1997): Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin 6. Cancer Immunol. Immunother., 45, 37-44.
3. ARMSTRONG Ch. A. MURRAY N., KENNEDY M., KOPPULA S. V., TARA D. and ANSEL J. C. (1994): Melanoma-derived IL-6 inhibits in vivo melanoma growth. J. Invest. Dermatol., 102, 278-284.
4. BARTON N. E., JACKSON J. V., LEE F. and WAGNER J. (1994): Oncostatin M stimulates proliferation in B9 hybridoma cells: potential role of Oncostatin M in plasmacytoma development. Cytokine, 6, 147-153.
5. BOMIRSKI A. (1977): Biological properties of transplantable melanomas in the Syrian hamster during 16 years maintenance by serial passages. Acad. Med. Gdańsk.
6. BOMIRSKI A., DOMINICZAK T. and NOWIŃSKA L. (1962): Spontaneous transplantable melanoma in the golden hamster. Acta Union Int. Cancer. 18, 178-180.
7. BROWN T. J., ROWE J. M., LIU J. and SHOYAB M. (1991): Regulation of IL-6 expression by Oncostatin M. J. Immunol., 147, 2175-2180.
8. COLOMBO M. P., MACCALLI C., MATTEI S., MELANI C., RADRIZZANI M. and PARMIANI G. (1992): Expression of cytokine genes including IL-6, in human malignant melanoma cell lines. Melanoma Res., 2, 181-189.
9. DOUGHERTY G. I., THACKER J. D., LAVEY R. S., BELLDEGRUN A. and MCBRIDE W. H. (1994): Inhibitory effects of locally produced and exogenous interleukin-6 on tumor growth in vivo. Cancer Immunol. Immunother., 38, 339-345.
10. HASDAY D., SHAH M. and LIEBERMAN P. (1990): Macrophage tumor necrosis factor-α release is induced by contact with some tumors. J. Immunol., 145, 371-379.
11. HEYMANN D., BLANCHARD F., RAHER S., DEGROOTE D. and GODARD A. (1995): Modulation of LIF expression in human melanoma cells by Oncostatin M. Immunol. Lett., 46, 245-251.
12. JANICKE R. and MANNEL D. N. (1990): Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. J. Immunol., 144, 1144-1150.
13. JIANG H., STEWART Ch. A., FAST D. J. and LEU R. (1992): Tumor target-derived soluble factor synergizes with IFN-γ and IL-2 activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. J. Immunol., 149, 2137-2146.
14. JOVANOVIC D. V., DI BATTISTA J. A., MARTEL-PELLETIER J., JOLICOEUR F. C., HE Y., ZHANG M., MINEAU F. and PELLETIER J. P. (1998): IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol., 160, 3513-3521.
15. KOBAYASHI H. (1994): Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype. Am. J. Pathol., 144, 776-786.
16. KLOSTERGAARD I. (1993): The role of nitric oxide in macrophage tumor cytotoxicity. In LOPEZ-BERESTEIN G. and KLOSTERGAARD I. (eds.): Mononuclear phagocytes in cell biology. CRC Press, Boca Raton, FL, 31-45.
17. KOZŁOWSKA K. and CICHOREK M. (1992): Modyfikacja cytotoksycznej aktywności czynników wydzielanych przez makrofagi zwia̧zane z rozwojem czerniaków przeszczepialnych. Acta Biol. Med., 18, 61-68.
18. KOZŁOWSKA K. and CICHOREK M. (1995): Ocena naturalnej cytotoksyczności makrofagów otrzcwnowych w aspekcie progresji czerniaków przeszczepialnych. Ann. Acad. Med. Gedan, 23, 239-249.
19. KOZŁOWSKA K., NOWAK J., KWIATKOWSKI B. and CICHOREK M. (1998): ESR study of plasmatic membrane of the transplantable melanoma cells in relation to their biological properties. Exp. Toxicol. Pathol., 50, 482-485.
20. KOZŁOWSKA K., ŻURAWSKA-CZUPA B. and KOSTULAK A. (1987): Changes of expression of peritoneal macrophages Fc and C3 receptor induced by transplantable melanomas. Folia Histochem. Cytobiol., 25, 203-208.
21. KOZŁOWSKA K., ŻURAWSKA-CZUPA B., MIERZEWSKI P. and KOSTULAK A. (1980): Use of the macrophage migration inhibition test to evaluate antigenic differences in golden hamster transplantable melanomas. Int. J. Cancer, 26, 211-215.
22. LINSLEY P. S., BOLTON-HANSON M., HORN D., MALIK N., KALLESTAD J. C., OCHS V., ZARLING J. M. and SHOYAB M. (1989): Identification and characterization of cellular receptor for the growth regulator. Oncostatin M. J. Biol. Chem., 264, 4282-4289.
23. LOWRY J., ROSENBROUGH N. FARR R. and RANDEL R. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem., 19, 265-275.
24. LU CH., RAK J. W., KOBAYASHI H. and KERBEL R. S. (1993): Increased resistance to Oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res., 53, 2708-2711.
25. MAEDA H., KUWAHARA H., ICHIMURA Y. and OHTSUKI M. (1995): TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol., 155, 4926-4932.
26. MALIK N., EVANS B., GREENFIELD B. W., SHAPIRO R. A., HANSON M. and SHOYAB M. (1994): Autocrine/paracrine induction of tissue inhibitor of metaloproteinase-1 in Chinese hamster ovary cells by Oncostatin M. Matrix Biol., 14, 677-680.
27. MALIK N., KALLESTAD J. C., GUNDERSON N. L., AUSTIN S. D., NEUBAUER M. G., OCHS V., MARQUARDT H., ZARLING Y. M., SHOYAB M., WEI CH., LINSLEY P. S. and ROSE T. M. (1989): Molecular cloning, sequence analysis and functional expression of a novel growth regulator, Oncostatin M. Mol. Cell. Biol., 9, 2847-2853.
28. MCDONALD V. L., DICK K., MALIK N. and SHOYAB M. (1993): Selection and characterization of a variant of human melanoma cell line, A 375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6). Growth Factors, 9, 167-175.
29. MOROHOSHI M., FUJISAWA K., UCHIMURA I. and NUMAHO F. (1996): Glucose-dependent interleukin 6 and tumor necrosis factor production by human periphcrial blood monocytes in vitro. Diabetes, 45, 954-959.
30. MOSMANN T. (1983): Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assay. J. Immunol. Methods, 65, 55-63.
31. OSTROVE J. and GIFFORD G. (1979): Stimulation of RNA synthesis in L929 cells by rabbit TNF. Proc. Soc. Exp. Biol. Med., 160, 354-358.
32. REVEL M. (1992): Growth regulatory functions of IL-6 and antitumour effects. Res. Immunol., 143, 760-773.
33. SCHINDLER R., MARCILLA J., ENDRES S., GHORBANI R., CLARK S. C. and DINARELLO Ch. A. (1990): Correlations and interactions in the production of interleukin 6 (IL-6), IL-1, and TNF in blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood, 75, 40-17.
34. SILVANI A., FERRARI G., PAONESSA G., TONIATTI C., PARMIANI G and COLOMBO M. P. (1995): Down-regulation of interleukin 6 receptor α chain in interleukin 6 transduced melanoma cells causes selective resistance. Cancer Res., 55, 2200-2205.
35. SWOPE B. V., ABDEL-MALEK Z., KASSEM L. M. and NORDLUN J. J. (1991): Interleukins 1α and 6 and tumor necrosis factor α are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J. Invest. Dermatol., 96, 180-185.
36. URSUGI T., SCHROIT A., CONNOR J., BUCANA C. and FIDLER J. (1991): Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res., 51, 3062-3066.
37. ZHANG Y. (1990): Interleukin 6 induction by tumor necrosis factor and interleukin 1 in human fibroblast involves activation of a nuclear factor binding to a B-like sequence. Mol. Cell. Biol., 10, 3818-3823.
38. ŻURAWSKA-CZUPA B. and KOZŁOWSKA K. (1978): A simple method for obtaining pure fraction of hamster's peritoneal macrophages. Arch. Immunol. Ther. Exp., 26, 441-443.